Bookmark and Share
peroxisome proliferator-activated receptor ga.. [gi:20336229] - Target BioActivity Data
Also known as: peroxisome proliferator-activated receptor gamma isoform 2 [Homo sapiens].
Filters: All Data » Active      
Filter selected
BioActivity Outcomes:
Probe(1)
 
 
Active(5141)
 
 
BioAssay Types:
Screening(3040)
 
 
Confirmatory(428)
 
 
Literature(164)
 
 
BioActivity Types:
EC50(225)
 
 
IC50(203)
 
 
Substance Types:
Chemical(5142)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 25    Data Row: 5142   Total Pages: 103   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID124349301]
[CID53239856]
Late stage assay provider counterscreen results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): chemiluminescence-based biochemical western blot assay for inhibitors of phosphorylation of PPARG protein levels [AID504938, Type: other]
View
2
[SID124349300]
IC50 0.00037Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): TR-FRET-based biochemical dose response competitive binding lanthascreen assay for non-agonists of the PPARg [AID504943, Type: confirmatory]
View
3
[SID104223102]
EC50 0.0005Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): Luminescence-based cell-based dose response assay to identify transactivation inhibitor of PPRE (PPARG response element) [AID504939, Type: confirmatory]
View
4
[SID104223102]
IC50 0.00054Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): TR-FRET-based biochemical dose response competitive binding lanthascreen assay for non-agonists of the PPARg [AID504943, Type: confirmatory]
View
5
[SID124349300]
EC50 0.00054Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): Luminescence-based cell-based dose response assay to identify transactivation inhibitor of PPRE (PPARG response element) [AID504939, Type: confirmatory]
View
6
[SID118043696]
EC50 0.002Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): Luminescence-based cell-based dose response assay to identify transactivation inhibitor of PPRE (PPARG response element) [AID504939, Type: confirmatory]
View
7
[SID118043696]
IC50 0.002Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): TR-FRET-based biochemical dose response competitive binding lanthascreen assay for non-agonists of the PPARg [AID504943, Type: confirmatory]
View
8
[SID104223105]
EC50 0.002Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): Luminescence-based cell-based dose response assay to identify transactivation inhibitor of PPRE (PPARG response element) [AID504939, Type: confirmatory]
View
9
[SID124349302]
IC50 0.004Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): TR-FRET-based biochemical dose response competitive binding lanthascreen assay for non-agonists of the PPARg [AID504943, Type: confirmatory]
View
10
[SID104223105]
IC50 0.006Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): TR-FRET-based biochemical dose response competitive binding lanthascreen assay for non-agonists of the PPARg [AID504943, Type: confirmatory]
View
11
[SID118043694]
IC50 0.006Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): TR-FRET-based biochemical dose response competitive binding lanthascreen assay for non-agonists of the PPARg [AID504943, Type: confirmatory]
View
12
[SID124349305]
EC50 0.021Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): Luminescence-based cell-based dose response assay to identify transactivation inhibitor of PPRE (PPARG response element) [AID504939, Type: confirmatory]
View
13
[SID124349303]
IC50 0.024Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): TR-FRET-based biochemical dose response competitive binding lanthascreen assay for non-agonists of the PPARg [AID504943, Type: confirmatory]
View
14
[SID124349305]
IC50 0.029Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): TR-FRET-based biochemical dose response competitive binding lanthascreen assay for non-agonists of the PPARg [AID504943, Type: confirmatory]
View
15
[SID22401659]
[CID1234827]
IC50 0.05552Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View
16
[SID124349301]
[CID53239856]
IC50 0.08Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): TR-FRET-based biochemical dose response competitive binding lanthascreen assay for non-agonists of the PPARg [AID504943, Type: confirmatory]
View
17
[SID118043694]
EC50 0.116Late stage assay provider results from the probe development effort to identify non-agonists of the peroxisome proliferator-activated receptor gamma (PPARg): Luminescence-based cell-based dose response assay to identify transactivation inhibitor of PPRE (PPARG response element) [AID504939, Type: confirmatory]
View
18
[SID91762765]
[CID1328217]
IC50 0.152Fluorescence-polarization-based biochemical polarscreen dose response binding assay for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg) [AID504453, Type: confirmatory]
View
19
[SID14746391]
[CID1262634]
IC50 0.15203Counterscreen for NR2E3 inverse agonists: TR-FRET-based biochemical high throughput dose response assay to identify inverse agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID463257, Type: confirmatory]
View
20
[SID91762729]
[CID3442864]
IC50 0.173Fluorescence-polarization-based biochemical polarscreen dose response binding assay for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg) [AID504453, Type: confirmatory]
View
21
[SID91762729]
[CID3442864]
EC50 0.181Luminescence-based cell-based assay provider high throughput dose response assay for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg) [AID504447, Type: confirmatory]
View
22
[SID91762765]
[CID1328217]
IC50 0.194TR-FRET-based biochemical dose response competitive binding lanthascreen assay for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg) [AID504446, Type: confirmatory]
View
23
[SID17386669]
[CID990754]
IC50 0.19621Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View
24
[SID17387489]
[CID1234281]
IC50 0.20872Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View
25
[SID49680219]
[CID2817025]
IC50 0.23665Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View
26
[SID26728053]
[CID2817166]
IC50 0.23701Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View
27
[SID49732562]
[CID1201252]
IC50 0.276TR-FRET-based biochemical dose response competitive binding lanthascreen assay for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg) [AID504446, Type: confirmatory]
View
28
[SID91762765]
[CID1328217]
EC50 0.283Luminescence-based cell-based assay provider high throughput dose response assay for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg) [AID504447, Type: confirmatory]
View
29
[SID14738494]
[CID4640649]
IC50 0.35647Counterscreen for NR2E3 inverse agonists: TR-FRET-based biochemical high throughput dose response assay to identify inverse agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID463257, Type: confirmatory]
View
30
[SID49671956]
[CID755656]
IC50 0.39471Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View
31
[SID91762782]
[CID16813558]
EC50 0.495Luminescence-based cell-based assay provider high throughput dose response assay for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg) [AID504447, Type: confirmatory]
View
32
[SID91762771]
[CID20918677]
EC50 0.502Luminescence-based cell-based assay provider high throughput dose response assay for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg) [AID504447, Type: confirmatory]
View
33
[SID50085530]
[CID2815701]
IC50 0.50339Counterscreen for NR2E3 inverse agonists: TR-FRET-based biochemical high throughput dose response assay to identify inverse agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID463257, Type: confirmatory]
View
34
[SID14735731]
[CID2849148]
IC50 0.5772Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View
35
[SID91762729]
[CID3442864]
IC50 0.6TR-FRET-based biochemical dose response competitive binding lanthascreen assay for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg) [AID504446, Type: confirmatory]
View
36
[SID17431994]
[CID975392]
IC50 0.60389Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View
37
[SID91762781]
[CID18578712]
EC50 0.631Luminescence-based cell-based assay provider high throughput dose response assay for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg) [AID504447, Type: confirmatory]
View
38
[SID91762734]
[CID3152768]
EC50 0.7Luminescence-based cell-based assay provider high throughput dose response assay for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg) [AID504447, Type: confirmatory]
View
39
[SID17433362]
[CID1746420]
IC50 0.73674Counterscreen for NR2E3 inverse agonists: TR-FRET-based biochemical high throughput dose response assay to identify inverse agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID463257, Type: confirmatory]
View
40
[SID24811249]
[CID6099]
EC50 0.742TR-FRET dose response biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPAR gamma): non-selective agonists [AID1681, Type: confirmatory]
View
41
[SID91762749]
[CID3767405]
IC50 0.748TR-FRET-based biochemical dose response competitive binding lanthascreen assay for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg) [AID504446, Type: confirmatory]
View
42
[SID24830336]
[CID2317063]
IC50 0.77832Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View
43
[SID7977182]
[CID2928967]
IC50 0.79203Counterscreen for NR2E3 inverse agonists: TR-FRET-based biochemical high throughput dose response assay to identify inverse agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID463257, Type: confirmatory]
View
44
[SID49647582]
[CID757946]
IC50 0.934Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View
45
[SID49715605]
[CID22334119]
IC50 0.941Counterscreen for NR2E3 inverse agonists: TR-FRET-based biochemical high throughput dose response assay to identify inverse agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID463257, Type: confirmatory]
View
46
[SID24811249]
[CID6099]
EC50 0.958TR-FRET dose response biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPAR gamma): non-selective agonists [AID1679, Type: confirmatory]
View
47
[SID24786281]
[CID12748881]
EC50 1.003TR-FRET dose response biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPAR gamma): non-selective agonists [AID1679, Type: confirmatory]
View
48
[SID49725089]
[CID9916275]
IC50 1.025Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View
49
[SID24783437]
[CID23679856]
IC50 1.089Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View
50
[SID7971194]
[CID2158311]
IC50 1.108Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput dose response assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear receptor co-repressor 2 (NCOR2) [AID2759, Type: confirmatory]
View